SALEEBY, E.; BIELINSKI, K.; FITZGERALD, A.; SIEGEL, J.; IBRAHIM, S. A Prospective, Multi-Center Clinical Utility Study Demonstrates That the 40-Gene Expression Profile (40-GEP) Test Impacts Clinical Management for Medicare-Eligible Patients with High-Risk Cutaneous Squamous Cell Carcinoma (cSCC). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. 482–496, 2022. DOI: 10.25251/skin.6.6.5. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/1788. Acesso em: 3 jul. 2024.